HR 2427 · 108th Congress · Health

Pharmaceutical Market Access Act of 2003

Introduced 2003-06-11· Sponsored by Rep. Gutknecht, Gil [R-MN-1]· House

Bill Progress

Introduced
Committee
House Vote
4
Senate
5
Enacted
Latest: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2003-07-25)

Recorded Votes

PassedHouse · 2003-07-25
Roll #445
Yea 243Nay 186
Democrats
155 Yea·45 Nay
Republicans
87 Yea·141 Nay
PassedHouse · 2003-07-25
Roll #445
Yea 243Nay 186
Democrats
155 Yea·45 Nay
Republicans
87 Yea·141 Nay

How Did Your Rep Vote?

Enter a ZIP code or representative's name

Plain Language Summary

[AI summary unavailable — showing source text] Pharmaceutical Market Access Act of 2003 - Amends the Federal Food, Drug and Cosmetic Act to direct the Secretary of Health and Human Services to promulgate regulations allowing qualifying individuals to import covered products (in addition to pharmacists and wholesalers, whom current law authorizes to import such products). Amends provision pertaining to record keeping regarding imported covered products. States that the Secretary shall not have to store records in cases in which qualifying individuals have imported a covered product. Amends provisions regarding the testing of imported covered products. Declares that specified tests, including ones involving authenticity and degradation of products, shall not be required unless the importer is a wholesaler. Requires such tests to be conducted by the importer unless a product is a prescription drug subject to the provisions of this Act pertaining to counterfeit-resistant packaging. (Currently either the importer or the manufacturer may conduct such tests). Eliminates the sunset date current law establishes for the provisions pertaining to the importation of covered products. Classifies prescription drugs as misbranded if they do no…

Summarized by Claude AI · Non-partisan · For informational purposes only

CBO Cost Estimate

Congressional Budget Office

H.R. 2427, Pharmaceutical Market Access Act of 2003

Nov 19, 2003

<p>Cost estimate for the bill as passed by the U.S. House of Representatives on July 25, 2003</p>

Full CBO report ↗

H.R. 2427, Pharmaceutical Market Access Act of 2003

Nov 19, 2003

Cost estimate for the bill as passed by the U.S. House of Representatives on July 25, 2003

Full CBO report ↗

Official non-partisan budget analysis by the Congressional Budget Office

Cosponsors (20)

2 Democrats18 Republicans